Fintel reports that on November 20, 2025, Cantor Fitzgerald reiterated coverage of Palo Alto Networks (NasdaqGS:PANW) with a ...
Fintel on MSN
Cantor Fitzgerald Initiates Coverage of Lexeo Therapeutics (LXEO) with Overweight Recommendation
Fintel reports that on November 20, 2025, Cantor Fitzgerald initiated coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a ...
1don MSN
Cantor Fitzgerald Boosts Tesla (TSLA) Price Target as New Production Plans Accelerate Growth Outlook
Tesla Inc. (NASDAQ:TSLA) ranks among the best sustainability stocks to invest in. On October 27, Cantor Fitzgerald maintained ...
Bloomberg on MSN
Lutnick Sons See Record Year as Cantor Denies Trump Conflicts
Cantor Fitzgerald, a New York financial boutique, is controlled by Brandon and Kyle Lutnick, the sons of Howard Lutnick, who ...
The No. 2 Northampton boys soccer team defeated No. 26 Agawam 2-0 in Friday night’s MIAA Division 2 state tournament Round of ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
Margins and 3.9-Month Payback—Central to Cantor’s Bullish OutlookCantor Notes PRE’s ~$120M Liquidity and 387 BTC ...
Cantor Fitzgerald analyst Jay Kornreich maintained a Buy rating on NETSTREIT today and set a price target of $21.00. The company’s shares closed today at $18.62. Take advantage of TipRanks Premium at ...
The Forward on MSN
Following uproar, IDF cantor to perform at Amsterdam Hanukkah concert after all — but not for everyone
The IDF’s chief cantor will be allowed to perform for Hanukkah in Amsterdam’s Royal Concert Hall — but not for everyone — after tensions over Israel ripped through one of ...
Thirteen years after Superstorm Sandy, new data shows 34,000 Long Island businesses face major flood risks that could cost ...
Ben Bourgeois is a far cry from a jaded former pro surfer reminiscing about the good ol’ days. At 47 years old, he retains a ...
Fintel reports that on November 5, 2025, Cantor Fitzgerald upgraded their outlook for Madrigal Pharmaceuticals (NasdaqGS:MDGL) from Neutral to Overweight. As of October 30, 2025, the average one-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results